Virtual Grand Rounds: Staying Up to Date with Endometrial Cancer
Activity Overview
How much do you know about the latest treatment advances in endometrial cancer? Join Dr. Monk and Dr. Barber on the Medscape Oncology/GOG Foundation, Inc., live webinar, Virtual Grand Rounds: Staying Up to Date With Endometrial Cancer, to find out. Dr. Monk and Dr. Barber will cover the latest clinical trial data, patient selection, adverse event management, and other clinical implications. Be prepared to ask your most pressing questions on endometrial cancer management!
The GOG Foundation, Inc. and Medscape Oncology is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: Eisai Inc., Karyopharm Theapeutics and Merck.
Target Audience
This activity is intended for gynecologic oncologists, medical oncologists, oncologists, obstetricians & gynecologists, and pathologists.
Learning Objectives
Upon completion of the activities in this series, learners will demonstrate:
Increased knowledge regarding:
-
- The key clinical trial data for newer therapies in endometrial cancers
- Important biomarkers to help identify eligible patients with endometrial cancers to receive immunotherapy
Greater competence related to:
-
- Selecting immunotherapy-based treatment for patients with endometrial cancer
- Mitigating immune-related adverse events (irAEs) in patients with endometrial cancer receiving immunotherapy
Faculty
Dr. Bradley J. Monk
Dr. Emma L. Barber
Agenda & Presentation Materials
Virtual Grand Rounds: Staying Up to Date with Endometrial Cancer
Presented on Tuesday, December 14, 2021, 1:30 pm – 2:00 pm ET
Continuing Education
In support of improving patient care, this activity has been developed through a collaboration between The GOG Foundation, Inc. (GOG) and Medscape Oncology.
Accreditation Statement
In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA PRA Category 1 Credits™
Medscape, LLC designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Declaration
In compliance with ACCME regulations, The GOG Foundation, Inc., as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. All reported conflicts are managed by a designated official to ensure a bias-free presentation. Please see the faculty disclosure for detailed information.
Bradley J. Monk, MD, FACOG, FACS, has disclosed the following relevant financial relationships:
- Advisor or consultant for: Agenus; Akeso Bio; Aravive; AstraZeneca; Clovis; Eisai; Elevar; EMD Merck; Genentech; Genmab; GlaxoSmithKline; GOG Foundation; Gradalis; ImmunoGen; Iovance; Karyopharm; Merck; Mersana; Myriad; Novocure; Pfizer; Puma; Regeneron; Roche; Seattle Genetics; Sorrento; Tesaro; US Oncology Research; VBL Therapeutics
- Speaker or a member of a speakers bureau for: AstraZeneca; Clovis; Eisai; Genentech; GlaxoSmithKline; Merck; Roche; Tesaro
- Other: Investigator for US Oncology Research
Emma L. Barber, MD, has disclosed the following relevant financial relationships:
- Speaker or a member of a speakers bureau for: Merck
- Received Grants for clinical research from: Eli Lilly
Technical Requirements
You will receive a link to this activity approximately three days prior to the scheduled symposia date. This virtual activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.